A Retrospective, cohort study to evaluate the efficacy associated with RSV-related hospitalizations in preterm infants of 28 weeks of GA treated with Palivizumab
Latest Information Update: 09 Jun 2017
At a glance
- Drugs Palivizumab (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 09 Jun 2017 New trial record